“genentech” Archives

in
Entry Author Date Location
Lacking Details, Roche Touts Drug Combo’s Success in Lung Cancer 11/20/17 San Francisco
Bio Roundup: ICER Eyes Cost, Azar at HHS, Gates’s ALZ Cash & More 11/17/17 National
FDA Approves Genentech Hemophilia Drug, But Adds Safety Warning 11/16/17 San Francisco
Bio Roundup: Barron Joins GSK, Sage Bounces Back, Valeant Dumps Addyi 11/10/17 National
Halozyme Inks $105M Bristol-Myers Partnership, Expands Roche Deal 09/14/17 San Diego
23andMe Raises $250M For Consumer Disease-Risk Tests, Drug R&D 09/12/17 San Francisco
Jazz Pharma, ImmunoGen Strike Up Drug Pact in Leukemia and More 08/29/17 Boston
To Be More Than Quick Splash, Gilead’s CAR-T Purchase Faces Hurdles 08/28/17 San Francisco
Ophthotech’s Final Try at Combo Eye Drug Comes up Short 08/14/17 New York
Dermira Commits $135M for Global Rights to Roche Eczema Drug 08/08/17 San Francisco
With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug 08/01/17 Boston
Merck Drug Shows No Life-Extending Benefit in Head-and-Neck Cancer 07/24/17 Boston
Genentech’s Hemophilia Drug Slashes Bleeding Rates, Early Data Show 06/26/17 San Francisco
In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions 05/31/17 National
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy 05/30/17 National
Bio Roundup: Big Apple Mo’, Checkpoint Yes and No, CAR-T Death & More 05/12/17 National
Merck Immunotherapy Drug Notches Another FDA Win in Lung Cancer 05/11/17 New York
Stalled or Rising Momentum? New York Wrestles With Its Biotech Future 05/10/17 New York
Genentech Drug Fails to Beat Chemo in Treating Advanced Bladder Cancer 05/10/17 San Francisco
Will New Data Open “Bottlenecks” For Biogen’s Pricey Spine Drug? 04/26/17 Boston
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis 04/26/17 Boston
Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street 04/17/17 Raleigh Durham
New Blood: Biotech CEOs Bring Fresh Experience to Houston Ecosystem 04/03/17 Texas
To Infinity and Beyond: Julian Adams on Missteps and His New Job 04/03/17 Boston
With FDA Approval, Genentech Drug Becomes First For Severe MS Cases 03/29/17 San Francisco
BioClin Gets $30M to Back More Bladder Cancer Drug Trials 03/22/17 San Francisco
First Trial Underway, CytomX Gets $200M More In Expanded Bristol Pact 03/20/17 San Francisco
No Details Yet, But Genentech Drug Combo Wins in Big Breast Cancer Study 03/02/17 San Francisco
Join Xconomy in June for ‘What’s Hot In Cancer Immunotherapy 2017’ 03/01/17 Seattle
Foundation, Roche Deepen Ties as Genentech Vet Steps in for CEO Pellini 01/06/17 Boston
Page 1 of 19 next page »